ES2229254T3 - Aposito estructurado oclusivo. - Google Patents
Aposito estructurado oclusivo.Info
- Publication number
- ES2229254T3 ES2229254T3 ES96301412T ES96301412T ES2229254T3 ES 2229254 T3 ES2229254 T3 ES 2229254T3 ES 96301412 T ES96301412 T ES 96301412T ES 96301412 T ES96301412 T ES 96301412T ES 2229254 T3 ES2229254 T3 ES 2229254T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- wound
- polymers
- occlusive
- structured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims abstract description 122
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 229920001187 thermosetting polymer Polymers 0.000 claims abstract 4
- 239000000463 material Substances 0.000 claims description 70
- 229920000642 polymer Polymers 0.000 claims description 44
- -1 polyethylene Polymers 0.000 claims description 16
- 235000019271 petrolatum Nutrition 0.000 claims description 15
- 239000000499 gel Substances 0.000 claims description 11
- 229920001400 block copolymer Polymers 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 8
- 229920000573 polyethylene Polymers 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000001993 wax Substances 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229920001971 elastomer Chemical group 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- XYWMWLADMNOAAA-UHFFFAOYSA-N acetic acid;buta-1,3-diene Chemical group CC(O)=O.C=CC=C XYWMWLADMNOAAA-UHFFFAOYSA-N 0.000 claims description 3
- 230000000845 anti-microbial effect Effects 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 239000005060 rubber Chemical group 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 229920002367 Polyisobutene Polymers 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000001754 anti-pyretic effect Effects 0.000 claims description 2
- 239000002221 antipyretic Substances 0.000 claims description 2
- 150000002148 esters Chemical group 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 2
- 229920001519 homopolymer Polymers 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 235000010446 mineral oil Nutrition 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- GVPDNFYOFKBFEN-UHFFFAOYSA-N trimethyl(octadecoxy)silane Chemical compound CCCCCCCCCCCCCCCCCCO[Si](C)(C)C GVPDNFYOFKBFEN-UHFFFAOYSA-N 0.000 claims description 2
- 210000002268 wool Anatomy 0.000 claims description 2
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 229920001038 ethylene copolymer Polymers 0.000 claims 1
- 239000012184 mineral wax Substances 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 42
- 208000027418 Wounds and injury Diseases 0.000 abstract description 41
- 239000002904 solvent Substances 0.000 abstract description 16
- 230000002209 hydrophobic effect Effects 0.000 abstract description 12
- 230000035876 healing Effects 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 description 42
- 230000001070 adhesive effect Effects 0.000 description 42
- 239000002674 ointment Substances 0.000 description 38
- 238000000034 method Methods 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 14
- 230000035807 sensation Effects 0.000 description 13
- 239000000758 substrate Substances 0.000 description 12
- 229920002633 Kraton (polymer) Polymers 0.000 description 11
- 239000000654 additive Substances 0.000 description 11
- 229940099259 vaseline Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229920003345 Elvax® Polymers 0.000 description 4
- 239000004264 Petrolatum Substances 0.000 description 4
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229910000077 silane Inorganic materials 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000003871 white petrolatum Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 108010001478 Bacitracin Proteins 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 206010053317 Hydrophobia Diseases 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010037742 Rabies Diseases 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 108010093965 Polymyxin B Proteins 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 229940053050 neomycin sulfate Drugs 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229960003548 polymyxin b sulfate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001417527 Pempheridae Species 0.000 description 1
- 241000404144 Pieris melete Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JPPGWVWBAJLHCE-UHFFFAOYSA-N buta-1,3-diene;ethene Chemical compound C=C.C=CC=C JPPGWVWBAJLHCE-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00885—Plasters pervious to air or vapours impervious, i.e. occlusive bandage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Magnetic Treatment Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Earth Drilling (AREA)
- Joining Of Building Structures In Genera (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US560248 | 1983-12-12 | ||
| US39759695A | 1995-03-02 | 1995-03-02 | |
| US397596 | 1995-03-02 | ||
| US08/560,248 US5814031A (en) | 1995-03-02 | 1995-11-21 | Structured occllusive dressings |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2229254T3 true ES2229254T3 (es) | 2005-04-16 |
Family
ID=23571846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96301412T Expired - Lifetime ES2229254T3 (es) | 1995-03-02 | 1996-03-01 | Aposito estructurado oclusivo. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5814031A (enExample) |
| EP (1) | EP0732108B1 (enExample) |
| JP (1) | JPH08336555A (enExample) |
| CN (2) | CN1142400A (enExample) |
| AT (1) | ATE278426T1 (enExample) |
| AU (2) | AU700357B2 (enExample) |
| BR (1) | BR9600876A (enExample) |
| CA (1) | CA2170838C (enExample) |
| DE (1) | DE69633534T2 (enExample) |
| DK (1) | DK0732108T3 (enExample) |
| ES (1) | ES2229254T3 (enExample) |
| PT (1) | PT732108E (enExample) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5814031A (en) * | 1995-03-02 | 1998-09-29 | Mooney; Mark | Structured occllusive dressings |
| ES2189981T3 (es) * | 1996-10-22 | 2003-07-16 | Coloplast As | Una pasta. |
| DE19804665B4 (de) * | 1998-02-06 | 2004-09-23 | Beiersdorf Ag | Lichtundurchlässiges Augenokklusionspflaster |
| US6703211B1 (en) | 1998-03-13 | 2004-03-09 | Promega Corporation | Cellular detection by providing high energy phosphate donor other than ADP to produce ATP |
| CN1188176C (zh) * | 1998-11-24 | 2005-02-09 | 强生消费者公司 | 用于敷料和绷带上起施用活性成分作用的涂层 |
| US20020015726A1 (en) | 2000-06-30 | 2002-02-07 | Scamilla Aledo Maria Aparecida De Carvalho | Dressings and bandages comprising same |
| JP2000351727A (ja) * | 1999-06-09 | 2000-12-19 | Hitoshi Saito | 貼用薬及びその製造装置 |
| US6294205B1 (en) | 1999-11-29 | 2001-09-25 | Brenda Jean Hollenbeck | Botanical composition for soothing skin |
| GB2362100B (en) * | 2000-05-08 | 2002-05-08 | Maelor Pharmaceuticals Ltd | Wound gels |
| SE521380C2 (sv) * | 2000-10-02 | 2003-10-28 | Moelnlycke Health Care Ab | Hudvidhäftande sårförband innefattande limmatris med fettsubstanser |
| US20020128615A1 (en) * | 2000-12-22 | 2002-09-12 | Tyrrell David John | Absorbent articles with non-aqueous compositions containing anionic polymers |
| US7771735B2 (en) | 2000-12-22 | 2010-08-10 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
| US20020172712A1 (en) * | 2001-03-19 | 2002-11-21 | Alan Drizen | Antiemetic, anti-motion sustained release drug delivery system |
| KR20030072418A (ko) * | 2002-03-04 | 2003-09-15 | 주식회사 도우파워텍 | 연고형태의 드레싱제가 도포된 상처치료용 드레싱 |
| DE10226990A1 (de) * | 2002-06-18 | 2004-03-18 | Sanguibiotech Ag | Topisch applizierbare Mikro-Emulsionen mit binärer Phasen- und Wirkstoffdifferenzierbarkeit, deren Herstellung und deren Verwendung, insbesondere zur Versorgung der Haut mit bioverfügbarem Sauerstoff |
| US7988990B2 (en) * | 2003-01-28 | 2011-08-02 | Teikoku Seiyaku Co., Ltd. | Thin aqueous cataplasm |
| US7371369B2 (en) * | 2003-11-10 | 2008-05-13 | Isp Investments Inc. | Polymeric interpenetrated network carrier and serial polymerization involving a crosslinked polymer network |
| US20050159368A1 (en) * | 2004-01-20 | 2005-07-21 | Stanley Johnston | Wound treatment composition and process of manufacture |
| US20110039690A1 (en) | 2004-02-02 | 2011-02-17 | Nanosys, Inc. | Porous substrates, articles, systems and compositions comprising nanofibers and methods of their use and production |
| US8025960B2 (en) * | 2004-02-02 | 2011-09-27 | Nanosys, Inc. | Porous substrates, articles, systems and compositions comprising nanofibers and methods of their use and production |
| DE102004031955A1 (de) * | 2004-06-24 | 2006-01-12 | Paul Hartmann Ag | Wundauflage |
| US7754248B2 (en) * | 2004-10-26 | 2010-07-13 | Johnson & Johnson Consumer Companies, Inc. | Ingestible compositions containing extracts |
| US20060088609A1 (en) * | 2004-10-26 | 2006-04-27 | Miri Seiberg | Compositions containing Cotinus coggygria extract and use thereof on mucosal tissues |
| US20060088608A1 (en) * | 2004-10-26 | 2006-04-27 | Miri Seiberg | Compositions containing cotinus coggygria extract and use thereof on skin and mucosal tissues |
| US20060165817A1 (en) * | 2004-10-26 | 2006-07-27 | Miri Seiberg | Compositions containing Cotinus coggygria extract and use thereof in treating wounds |
| US20070104806A1 (en) * | 2004-10-26 | 2007-05-10 | Miri Seiberg | Compositions containing cotinus coggygria extract and use thereof in treating hemorrhoids |
| US7295323B2 (en) * | 2005-03-31 | 2007-11-13 | Honeywell International Inc. | Adhesive system and method for forming a fiber optic gyroscope sensing coil |
| US7516592B1 (en) * | 2005-03-31 | 2009-04-14 | Pratt James M | Foundation crack sealer and method of use |
| GB0606661D0 (en) * | 2006-04-03 | 2006-05-10 | Brightwake Ltd | Improvements relating to dressings |
| DE102008017746A1 (de) | 2008-04-07 | 2009-10-08 | Beiersdorf Ag | Haut- oder Wundauflage zur feuchten Wundheilung |
| GB0809131D0 (en) * | 2008-05-20 | 2008-06-25 | Brightwake Ltd | Soft silicones tapes |
| CA2689472C (en) * | 2008-07-18 | 2019-01-15 | Karine Theberge | Articles of manufacture releasing an active ingredient |
| US20100030170A1 (en) * | 2008-08-01 | 2010-02-04 | Keith Alan Keller | Absorptive Pad |
| US8075537B2 (en) * | 2008-08-15 | 2011-12-13 | Oxyband Technologies, Inc. | Multiple cell therapeutic diffusion device |
| US20110282259A1 (en) * | 2009-03-09 | 2011-11-17 | Postel Olivier B | Methods of manufacture of a diffusion dressing |
| US8377015B2 (en) * | 2009-04-24 | 2013-02-19 | Alcare Co., Ltd. | Wound dressing and method for producing it |
| EP3859830B1 (en) * | 2009-05-19 | 2022-03-09 | OneD Material, Inc. | Nanostructured materials for battery applications |
| US20110077608A1 (en) * | 2009-09-25 | 2011-03-31 | Macedo Jr Carlos Da Silva | Cushioned adhesive bandage |
| US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| GB2493960B (en) | 2011-08-25 | 2013-09-18 | Brightwake Ltd | Non-adherent wound dressing |
| US20130150764A1 (en) * | 2011-12-09 | 2013-06-13 | Tyco Healthcare Group Lp | Non-Adherent Wound Dressings and Related Methods Therefor |
| US9402770B2 (en) | 2011-12-09 | 2016-08-02 | Covidien | Antimicrobial non-adherent dressings and related methods therefor |
| CN102994009B (zh) * | 2012-11-27 | 2015-02-25 | 明尼苏达矿业制造医用器材（上海）有限公司 | 水胶体粘合剂和水胶体敷料 |
| GB201222770D0 (en) | 2012-12-18 | 2013-01-30 | Systagenix Wound Man Ip Co Bv | Wound dressing with adhesive margin |
| US8966662B2 (en) * | 2012-12-28 | 2015-03-03 | Ajit Belliappa | Apparatus for a sleep mask |
| CN103349792B (zh) * | 2013-06-18 | 2015-08-26 | 重庆金老虎科技开发有限公司 | 新型创可贴 |
| KR101581025B1 (ko) * | 2014-06-16 | 2015-12-29 | (주) 타우피엔유메디칼 | 아치형 관상동맥 보호구가 일체화된 승모판막 서클라지 시술용 서클라지 로프 |
| WO2016124202A1 (en) | 2015-02-02 | 2016-08-11 | Coloplast A/S | Ostomy device |
| WO2016134445A1 (en) * | 2015-02-27 | 2016-09-01 | Albarrie Geocomposites Limited | Liquid hydrocarbon containment system |
| US10285862B2 (en) | 2015-03-13 | 2019-05-14 | Radicles, Inc. | Sleep mask apparatus |
| BR112017021501A2 (pt) | 2015-04-10 | 2018-07-03 | Coloplast As | ?dispositivo de ostomia, e, método para aplicação de um dispositivo de ostomia? |
| KR102132544B1 (ko) * | 2015-06-19 | 2020-07-09 | 글로벌 헬스 솔루션즈, 엘엘씨 | 활성 성분들을 위한 페트롤라툼-계 전달 시스템 |
| FR3044893B1 (fr) * | 2015-12-09 | 2018-05-18 | Emile Droche | Pansement pour soins de la peau en milieu humide |
| EP3544804B1 (en) * | 2016-11-24 | 2025-01-15 | Amcor Flexibles Transpac BVBA | Peelable seal layer |
| US20210337901A1 (en) * | 2020-04-30 | 2021-11-04 | Daniel William Jette | Attachable, removable, and disposable sweatband strip |
| US11759597B2 (en) * | 2020-06-07 | 2023-09-19 | Biocrede Inc. | Device for providing therapeutic gas |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4816144Y1 (enExample) * | 1970-08-03 | 1973-05-08 | ||
| US3867520A (en) * | 1971-04-14 | 1975-02-18 | Ajinomoto Kk | Medicated polyamino acid film for occlusive dressing therapy |
| JPS58108829U (ja) * | 1982-01-20 | 1983-07-25 | 株式会社 山形グラビヤ | 殺菌袋を併用した傷薬ばんそうこう |
| JPS61129833U (enExample) * | 1985-01-28 | 1986-08-14 | ||
| GB2192142B (en) * | 1986-07-04 | 1990-11-28 | Johnson & Johnson | Wound dressing |
| US4855335A (en) * | 1986-09-23 | 1989-08-08 | Findley Adhesives Inc. | Medical moisture resistant adhesive composition for use in the presence of moisture |
| US5059189A (en) * | 1987-09-08 | 1991-10-22 | E. R. Squibb & Sons, Inc. | Method of preparing adhesive dressings containing a pharmaceutically active ingredient |
| US5413567A (en) * | 1988-02-29 | 1995-05-09 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Primary packaging for surface-stabilized surgical dressing |
| JPH061135Y2 (ja) * | 1988-06-20 | 1994-01-12 | 積水化学工業株式会社 | 救急絆創膏 |
| US5006401A (en) * | 1988-11-23 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Composite compression and support dressing |
| US5411738A (en) * | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
| JPH02143925U (enExample) * | 1989-05-07 | 1990-12-06 | ||
| US5250043A (en) * | 1989-08-16 | 1993-10-05 | Castellana Frank S | Continent ostomate bandage |
| US5271943A (en) * | 1989-10-27 | 1993-12-21 | Scott Health Care | Wound gel compositions containing sodium chloride and method of using them |
| US5270358A (en) * | 1989-12-28 | 1993-12-14 | Minnesota Mining And Manufacturing Company | Composite of a disperesed gel in an adhesive matrix |
| FR2678513B1 (fr) * | 1991-07-03 | 1995-06-30 | Laboratoires Hygiene Dietetique | Pansement cicatrisant. |
| US5160328A (en) * | 1991-08-07 | 1992-11-03 | Ndm Acquisition Corp. | Hydrogel bandage |
| US5273756A (en) * | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
| US5423736A (en) * | 1992-04-02 | 1995-06-13 | New Dimensions In Medicine, Inc. | Wound dressing with dehydrated hydrogel gauze |
| GB9212450D0 (en) * | 1992-06-11 | 1992-07-22 | Indena Spa | New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them |
| AU679937B2 (en) * | 1992-11-18 | 1997-07-17 | Johnson & Johnson Consumer Products, Inc. | Extrudable compositions for topical or transdermal drug delivery |
| US5681579A (en) * | 1993-03-22 | 1997-10-28 | E.R. Squibb & Sons, Inc. | Polymeric support wound dressing |
| JPH0724049A (ja) * | 1993-07-06 | 1995-01-27 | Johnson & Johnson Kk | 救急絆創膏用粘着フィルムおよび該粘着フィルムを用いた救急絆創膏 |
| US5356372A (en) * | 1993-12-01 | 1994-10-18 | Ludlow Corporation | Occlusive pressure-reducing wound dressing |
| US5429592A (en) * | 1994-03-02 | 1995-07-04 | Euromed I/S | Occlusive dressing with striped precut release sheet |
| US5512041A (en) * | 1994-10-07 | 1996-04-30 | Scott Health Care | Wound dressing for promoting moist wound healing |
| US5814031A (en) * | 1995-03-02 | 1998-09-29 | Mooney; Mark | Structured occllusive dressings |
-
1995
- 1995-11-21 US US08/560,248 patent/US5814031A/en not_active Expired - Lifetime
-
1996
- 1996-02-29 AU AU45836/96A patent/AU700357B2/en not_active Ceased
- 1996-03-01 DK DK96301412T patent/DK0732108T3/da active
- 1996-03-01 CA CA002170838A patent/CA2170838C/en not_active Expired - Lifetime
- 1996-03-01 CN CN96105797.1A patent/CN1142400A/zh active Pending
- 1996-03-01 PT PT96301412T patent/PT732108E/pt unknown
- 1996-03-01 BR BR9600876A patent/BR9600876A/pt not_active IP Right Cessation
- 1996-03-01 AT AT96301412T patent/ATE278426T1/de active
- 1996-03-01 JP JP8082950A patent/JPH08336555A/ja active Pending
- 1996-03-01 EP EP96301412A patent/EP0732108B1/en not_active Expired - Lifetime
- 1996-03-01 DE DE69633534T patent/DE69633534T2/de not_active Expired - Lifetime
- 1996-03-01 ES ES96301412T patent/ES2229254T3/es not_active Expired - Lifetime
- 1996-03-01 CN CN200910205220.7A patent/CN101756765B/zh not_active Expired - Lifetime
-
1998
- 1998-09-15 US US09/153,408 patent/US6231872B1/en not_active Expired - Lifetime
-
1999
- 1999-04-01 AU AU23566/99A patent/AU2356699A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT732108E (pt) | 2004-12-31 |
| EP0732108A3 (en) | 1999-09-15 |
| AU700357B2 (en) | 1999-01-07 |
| JPH08336555A (ja) | 1996-12-24 |
| US5814031A (en) | 1998-09-29 |
| CN101756765A (zh) | 2010-06-30 |
| DE69633534D1 (de) | 2004-11-11 |
| DE69633534T2 (de) | 2005-12-29 |
| US6231872B1 (en) | 2001-05-15 |
| CA2170838C (en) | 2009-08-25 |
| AU2356699A (en) | 1999-05-27 |
| BR9600876A (pt) | 1997-12-30 |
| EP0732108A2 (en) | 1996-09-18 |
| CN1142400A (zh) | 1997-02-12 |
| DK0732108T3 (da) | 2005-02-07 |
| EP0732108B1 (en) | 2004-10-06 |
| CN101756765B (zh) | 2014-05-14 |
| AU4583696A (en) | 1996-09-12 |
| CA2170838A1 (en) | 1996-09-03 |
| ATE278426T1 (de) | 2004-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2229254T3 (es) | Aposito estructurado oclusivo. | |
| ES2244206T3 (es) | Compresa no adherente esteril. | |
| RU2332238C2 (ru) | Композиция для прокладок, раневых повязок и других изделий, контактирующих с кожей | |
| ES2441375T3 (es) | Parche para el tratamiento del herpes labial | |
| US6313369B1 (en) | Structured occlusive dressing | |
| JP2513712B2 (ja) | 創傷用ドレッシング | |
| US3328259A (en) | Dressing for a wound containing a hemostatic agent and method of treating a wound | |
| JP4558208B2 (ja) | 吸収包帯と包帯上の活性成分の分配器として有効なコーティング | |
| ES2526700T3 (es) | Composición de adhesivo | |
| CN101959539B (zh) | 水凝胶创伤被覆材料 | |
| US3249109A (en) | Topical dressing | |
| ES2333490T3 (es) | Aposito mejorado para heridas. | |
| ES2929890T3 (es) | Apósito para heridas | |
| PT94991B (pt) | Processo para a preparacao de sistemas para ostomizados continentes | |
| JP5089165B2 (ja) | 抗菌物質 | |
| CZ91099A3 (cs) | Hydrofilní adhezivní hmota a její použití | |
| JPH08336555A5 (enExample) | ||
| BR102012004427A2 (pt) | Adhesive bandage | |
| JPH0542179A (ja) | ロール状の創傷保護材 | |
| JPH09502367A (ja) | 外科用ドレッシング | |
| JP6147874B2 (ja) | 皮膚マスキング材 | |
| ES2610952T3 (es) | Apósito de contacto autoportante | |
| JPS63153068A (ja) | 接着性製品 | |
| ES2197118T3 (es) | Composiciones hidrocoidales adhesivas absorbentes de fluidos. | |
| Tan et al. | A comparison of ZenodermR with DuoDERM ER in the treatment of split skin graft donor sites |